Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-18-041308

Options or other derivatives

  • Director acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Russell Angus C. Director 2018-07-01 Grant or award · Option to Purchase Common Shares +40,000 40,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…